99 related articles for article (PubMed ID: 34130463)
1. Severe acute respiratory syndrome coronavirus 2 invasion in the central nervous system: a host-virus deadlock.
Baral PK; Nuruzzaman M; Uddin MS; Ferdous M; Chowdhury IH; Smrity SZ
Acta Virol; 2021; 65(2):115-126. PubMed ID: 34130463
[TBL] [Abstract][Full Text] [Related]
2. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
Baig AM
ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
[TBL] [Abstract][Full Text] [Related]
3. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
[TBL] [Abstract][Full Text] [Related]
4. Immune landscape and redox imbalance during neurological disorders in COVID-19.
Thakur A; Sharma V; Averbek S; Liang L; Pandya N; Kumar G; Cili A; Zhang K
Cell Death Dis; 2023 Sep; 14(9):593. PubMed ID: 37673862
[TBL] [Abstract][Full Text] [Related]
5. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
Pouga L
J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
[TBL] [Abstract][Full Text] [Related]
6. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.
Saleki K; Banazadeh M; Miri NS; Azadmehr A
Rev Neurosci; 2022 Feb; 33(2):147-160. PubMed ID: 34225390
[TBL] [Abstract][Full Text] [Related]
7. CNS implications of COVID-19: a comprehensive review.
Nagu P; Parashar A; Behl T; Mehta V
Rev Neurosci; 2021 Feb; 32(2):219-234. PubMed ID: 33550782
[TBL] [Abstract][Full Text] [Related]
8. Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain?
Baig AM
ACS Chem Neurosci; 2020 Oct; 11(20):3185-3187. PubMed ID: 33030333
[TBL] [Abstract][Full Text] [Related]
9. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
10. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
Zhang Y; Chen X; Jia L; Zhang Y
Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
[TBL] [Abstract][Full Text] [Related]
11. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-RodrÃguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
12. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients.
Veleri S
Exp Brain Res; 2022 Jan; 240(1):9-25. PubMed ID: 34694467
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
Singal CMS; Jaiswal P; Seth P
ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 invasion of the central nervous: a brief review.
Siddiqui R; Mungroo MR; Khan NA
Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684
[TBL] [Abstract][Full Text] [Related]
16. Does COVID-19 contribute to development of neurological disease?
Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
[TBL] [Abstract][Full Text] [Related]
17. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses.
Barrantes FJ
ACS Chem Neurosci; 2020 Sep; 11(18):2793-2803. PubMed ID: 32845609
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation.
Chaudhury SS; Sinha K; Majumder R; Biswas A; Mukhopadhyay CD
J Biosci; 2021; 46(2):. PubMed ID: 34047290
[TBL] [Abstract][Full Text] [Related]
20. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.
Baig AM; Khaleeq A; Ali U; Syeda H
ACS Chem Neurosci; 2020 Apr; 11(7):995-998. PubMed ID: 32167747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
